[May 27, 2015]

Research and Markets: Global Nonseminomatous Testicular Cancer Clinical Trials Report 2015

Research and Markets (http://www.researchandmarkets.com/research/8dlqdg/nonseminomatous) has announced the addition of the "Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015" report to their offering.

This report provides elemental information and data relating to the clinical trials on Nonseminomatous Testicular Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining tothe number of trials for the key drugs for treating Nonseminomatous Testicular Cancer.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)
  

Clinical Trial Overview of Top Institutes / Government

• Memorial Sloan Kettering Cancer Center
• National Cancer Institute
• Abramson Cancer Center
• Cambridge University Hospitals NHS Foundation Trust
• City of Hope
• Deutsche Krebshilfe e.V.
• European Organization for Research and Treatment of Cancer
• Indiana University (News - Alert) School of Medicine
• Institute of Cancer Research
• Masonic Cancer Center

For more information visit http://www.researchandmarkets.com/research/8dlqdg/nonseminomatous

View source version on businesswire.com: http://www.businesswire.com/news/home/20150527005943/en/

[ Back To TMCnet.com's Homepage ]